DL-amphetamine

CAS : 300-62-9

Ref. 3D-AAA30062

Informations sur le produit

• Nom: DL-amphetamine
• Synonymes: (.+-.)-1-Phenyl-2-aminopropane, (.+-.)-Desoxynorephedrine, (.+-.)-Phenylisopropylamine, (.+-.)-α-Methylphenethylamine, (.+-.)-α-Methylphenylethylamine, (.+-.)-β-Phenylisopropylamine, 1-Benzylethylamine, 1-Methyl-2-phenylethylamine, 1-Phenyl-2-propanamine, 1-Phenyl-2-propylamine, 2-Amino-1-phenylpropane, 3-Phenyl-2-propylamine, 3-Phenylpropan-2-amine, Actedron, Adderall, Adderall XR, Adipan, Allodene, Amfetamina, Amfetamine, Amphetamin, Amphetamine, Anorexine, Benzebar, Benzedrine, Benzolone, Elastonon, Fenopromin, Finam, Isoamyne, Isomyn, Mecodrin, Norephedrane, Novydrine, Nsc 27159, Obesin, Obesine, Oktedrin, Ortedrine, Percomon, Phenamine, Phenedrine, Phenethylamine, α-methyl-, (.+-.)-, Profamina, Propisamine, Racemic Amphetamine, Raphetamine, Rhinalator, Simpatedrin, Simpatina, Sli 381, Sympamine, Sympatedrine, Weckamine, dl-α-Methylphenethylamine, α-Methyl-β-phenylethylamine, α-Methylbenzeneethanamine, β-Aminopropylbenzene

Description

DL-amphetamine is a medicinal compound that has been shown to be an inhibitor of protein kinases. It has been studied extensively for its potential as an anticancer agent, particularly in tumor cells. DL-amphetamine has been shown to induce apoptosis in human and Chinese hamster ovary cells, which suggests that it may have potential as a cancer therapy. This compound is structurally similar to other kinase inhibitors, such as imatinib and dasatinib, and has been found in urine samples of individuals taking these drugs. While further research is needed to fully understand the potential therapeutic benefits of DL-amphetamine, its ability to inhibit kinases makes it a promising candidate for future cancer research.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 135.21 g/mol
• Formule: C₉H₁₃N
• Degré de pureté: Min. 95%